Keyphrases
Angiogenesis
9%
Biomimetic Peptide
10%
Brain Cancer
15%
Camptothecin
11%
Cancer Cells
10%
Cancer Gene Therapy
15%
Cargo
13%
Cellular Uptake
10%
Chemotherapy
14%
Deep Eutectic
24%
Deep Eutectic Solvents
21%
Dendritic Cells
14%
Derived Peptide
14%
Doxorubicin
19%
Erythrocytes
16%
Gemcitabine
11%
Gene Delivery
18%
Gene Therapy
32%
Glioblastoma
12%
Human Glioblastoma
13%
Hyaluronic Acid
10%
Immune Regulation
14%
Intraocular Injection
11%
Ionic Liquid
13%
Lipid Nanoparticles
9%
Lipids
13%
Lung Metastasis
14%
Macrophages
10%
Membrane Coating
13%
Messenger RNA (mRNA)
13%
Microparticles
11%
Nanocomplex
11%
Nanoparticle Formulation
12%
Nanoparticles
72%
Neovascular Age-related Macular Degeneration (nAMD)
16%
Neovascularization
10%
Ocular Neovascularization
19%
Poly(lactic-co-glycolic acid)
13%
Poly(β-amino ester)
33%
Polyethylene Glycol
28%
Polymeric Microparticles
13%
Polymeric Nanoparticles
36%
Polyphenols
19%
Polyplexes
12%
Small Interfering RNA (siRNA)
10%
Tannic Acid
10%
Tumor Growth
9%
Vascular Leakage
13%
Verteporfin
22%
α-amino Esters
19%
Pharmacology, Toxicology and Pharmaceutical Science
Adeno Associated Virus
6%
Antitumor Activity
6%
Brain Cancer
22%
Breast Cancer
8%
Camptothecin
10%
Cancer Inhibition
6%
Chemotherapy
16%
Choline
9%
Combination Drug
10%
Combination Therapy
7%
Copolymer
9%
Cytotoxicity
10%
Disease
9%
Doxorubicin
17%
Drug Conjugate
7%
Gene Delivery
30%
Glioblastoma
25%
Hyaluronic Acid
18%
Ionic Liquid
13%
Lung Metastasis
16%
Macrogol
25%
Macrogol Derivative
21%
Malignant Neoplasm
52%
Melanoma
13%
Messenger RNA
13%
Micelle
13%
Microparticle
16%
Mouse Model
9%
Nanocomposite
13%
Nanoparticle
100%
Neoplasm
35%
Neovascularization (Pathology)
22%
Nucleic Acid
8%
Peptide Antibody
6%
Pharmacokinetics
15%
Plasmid DNA
8%
Polyglactin
12%
Polyphenol
13%
Protein Tyrosine Kinase
6%
Small Cell Lung Cancer
6%
Small Interfering RNA
13%
Solid Lipid Nanoparticle
13%
Subcutaneous Injection
7%
Sustained Release
8%
Tannin
13%
Triple Negative Breast Cancer
6%
Tumor Growth
12%
Vasculotropin
11%
Verteporfin
26%
Wet Macular Degeneration
12%